Register
Medicines reference
Product

FeliShot PHC

Feline parvovirus + Feline herpesvirus + Feline calicivirus · Choong Ang Vaccine Laboratories Co., Ltd (CAVAC)

1 form: emulsion. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
1 ml inactivated vaccine, Emulsion · Cat Cat 1 ml (1 ml)
Shake before use and administer 1 ml by the selected route to a healthy cat. Do not vaccinate during pregnancy or when the cat has fever, severe malnutrition, infectious or parasitic disease, marked stress or immunosuppression. Possible hypersensitivity signs include anorexia, collapse, rash, vomiting or seizures; local pain, swelling or induration may occur. Bring to room temperature before use, use sterile equipment and one needle per animal, disinfect the injection site, avoid stress for one week before and after vaccination, store at 2-8 °C, protect from light and do not freeze.
· primary course from about 8 weeks: repeat after 3-4 weeks; booster annually
primary course from about 8 weeks: repeat after 3-4 weeks; booster annually Georgia Yes, veterinary
1 ml inactivated vaccine, Emulsion · Cat Cat 1 ml (1 ml)
Shake before use and administer 1 ml by the selected route to a healthy cat. Do not vaccinate during pregnancy or when the cat has fever, severe malnutrition, infectious or parasitic disease, marked stress or immunosuppression. Possible hypersensitivity signs include anorexia, collapse, rash, vomiting or seizures; local pain, swelling or induration may occur. Bring to room temperature before use, use sterile equipment and one needle per animal, disinfect the injection site, avoid stress for one week before and after vaccination, store at 2-8 °C, protect from light and do not freeze.
· primary course from about 8 weeks: repeat after 3-4 weeks; booster annually
primary course from about 8 weeks: repeat after 3-4 weeks; booster annually Georgia Yes, veterinary
Details: pack, label wording, sources, registration

FeliShot PHC 1 ml inactivated vaccine, Emulsion

10 vials for cats
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Cat
6.9/10
Situational / acceptable
vetman assessment

FeliShot PHC

1 ml inactivated vaccine, 10 vials for cats
Assessed clinical scopeCat · Full cat label from about 8 weeks: inactivated adjuvanted FPV, FHV-1 and FCV core immunisation · SC,IM
Care settingPreventive veterinary vaccination of a healthy, unstressed cat with examination and recorded injection site
vetman score 6.9/10 Situational / acceptable
Evidence confidence: Low Georgia: Yes, veterinary · № 310-11 · Verified on 22 Oct 2026

A situational inactivated core vaccine for cats: it covers the right three viruses, but modified-live FPV alternatives usually provide faster, more robust panleukopenia protection. Where suitable products exist, a non-adjuvanted option also follows WSAVA's conditional preference for reducing adjuvant-specific concern.

Regulatory and scientific credibility7.0/10

The exact product is registered in Georgia (310-11) and holds a current Korean APQA approval since 2006 with a public composition and label, but no EU, UK or US authorisation was documented in the reviewed evidence or independent product study.

Clinical efficacy7.0/10

It targets the three feline core viruses, but all antigens are inactivated: guidelines note slower and less robust protection than modified-live panleukopenia vaccines, especially with maternal antibody.

Safety and tolerability6.5/10

The exact label contraindicates use during pregnancy and lists collapse, vomiting and convulsions as possible reactions. It contains an oil adjuvant (Montanide); WSAVA conditionally prefers non-adjuvanted feline vaccines where alternatives exist, while noting that comparative injection-site sarcoma evidence remains uncertain and the benefit of vaccination outweighs this rare risk.

Clinical practicality7.5/10

A ready 1 ml liquid dose SC or IM, repeated after 3-4 weeks and boosted yearly, is simple, but the cat must be kept unstressed for a week before and after.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • Do not vaccinate pregnant cats or cats with fever, severe malnutrition, infectious or parasitic disease, marked stress or immunosuppression.
  • Possible reactions include anorexia, collapse, rash, vomiting and convulsions; observe after vaccination and keep emergency treatment ready.
  • This is an oil-adjuvanted vaccine: inject distally on a limb, record the site and investigate any persistent or growing lump.
  • All antigens are inactivated; continue kitten doses until 16 weeks or later because maternal antibody can block earlier doses.
  • Bring to room temperature and shake before use; store at 2-8 C, protect from light and do not freeze.
Assessment sources
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Feline parvovirus4.8 log10 TCID50/dose Feline herpesvirus6.2 log10 TCID50/dose Feline calicivirus6.2 log10 TCID50/dose
Formulation Type
Emulsion
Administration route
Subcutaneous, Intramuscular
Manufacturer (register)
KOMIPHARM INTERNATIONAL CO. LTD, South Korea
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 429, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml (1 ml)
Shake before use and administer 1 ml by the selected route to a healthy cat. Do not vaccinate during pregnancy or when the cat has fever, severe malnutrition, infectious or parasitic disease, marked stress or immunosuppression. Possible hypersensitivity signs include anorexia, collapse, rash, vomiting or seizures; local pain, swelling or induration may occur. Bring to room temperature before use, use sterile equipment and one needle per animal, disinfect the injection site, avoid stress for one week before and after vaccination, store at 2-8 °C, protect from light and do not freeze.
Cat Any weight Subcutaneous primary course from about 8 weeks: repeat after 3-4 weeks; booster annually
APQA FeliShot
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
FeliShot PHC - Korean veterinary medicinal product record
Korean Veterinary Medicinal Products Information, 2026
1 ml (1 ml)
Shake before use and administer 1 ml by the selected route to a healthy cat. Do not vaccinate during pregnancy or when the cat has fever, severe malnutrition, infectious or parasitic disease, marked stress or immunosuppression. Possible hypersensitivity signs include anorexia, collapse, rash, vomiting or seizures; local pain, swelling or induration may occur. Bring to room temperature before use, use sterile equipment and one needle per animal, disinfect the injection site, avoid stress for one week before and after vaccination, store at 2-8 °C, protect from light and do not freeze.
Cat Any weight Intramuscular primary course from about 8 weeks: repeat after 3-4 weeks; booster annually
APQA FeliShot
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
FeliShot PHC - Korean veterinary medicinal product record
Korean Veterinary Medicinal Products Information, 2026

Feline parvovirus: No dose supported by a publicly verifiable source yet

Feline herpesvirus: No dose supported by a publicly verifiable source yet

Feline calicivirus: No dose supported by a publicly verifiable source yet

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.